ALBAlbemarle Corporation
Is it growing?
Neither accelerating nor breaking down: revenue growing +18% year on year and operating margin widening (+21.6 points), but earnings down −103% year on year.
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, 2.6% now against -19.0% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is ALB growing?
Albemarle Corporation has grown revenue −15% a year over three years and 13% a year over five, with earnings per share compounding at −80%.
Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · shrinking · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +13%
Revenue growth, 5-year rate · −15% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- −80%
Earnings per share, 3-year rate · revenue −15% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 18
Years of annual history on file · FY2008 to FY2025, as filed
Details›
- Revenue FY2021
- $3.33B
- Revenue FY2022
- $7.32B
- Revenue FY2023
- $9.62B
- Revenue FY2024
- $5.38B
- Revenue FY2025
- $5.14B
Annual income statements as filed with the SEC.
Specialty Chemicals
The closest names by size in the same industry